January 6, 2024
India orders new drug manufacturing standards after deaths abroad
NEW DELHI: Indian pharmaceutical companies must meet new production standards this year, according to a government announcement released on Saturday, although smaller companies have asked for a delay, citing their debt. Shaken by a spate of deaths abroad linked to Indian-made drugs from 2022, Prime Minister Narendra Modi’s government has stepped up scrutiny of pharmaceutical factories to clean up the image of the $50 billion industry. “The manufacturer must take responsibility for the quality of medicinal products to ensure that they are suitable for their intended use, comply with the requirements of the license and do not put patients at


